<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Onanong Waleekhachonloet และผู้แต่งคนอื่นๆ. (2018) Financial Burdens on Patients with End Stage Renal Disease Receiving Renal Replacement Therapy. &lt;i&gt;Isan Journal of Pharmaceutical Sciences&lt;/i&gt;, &lt;i&gt;14&lt;/i&gt;(4), 79-87.</APA><Chicago>Onanong Waleekhachonloet และผู้แต่งคนอื่นๆ. "Financial Burdens on Patients with End Stage Renal Disease Receiving Renal Replacement Therapy". Isan Journal of Pharmaceutical Sciences  14 (2018):79-87.</Chicago><MLA>Onanong Waleekhachonloet และผู้แต่งคนอื่นๆ. Financial Burdens on Patients with End Stage Renal Disease Receiving Renal Replacement Therapy. Faculty of Pharmaceutical Sciences KKU MSU UBU:ม.ป.ท. 2018.</MLA></bibliography></xml>
